| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | Jan 23, 2024 | Sale | $8.85 | 180,000 | 1,593,459 | 119,024 | Jan 25, 2024, 04:46 PM | |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | Jun 22, 2023 | Option Exercise | $0.71 | 10,000 | 7,100 | 29,024 | Jun 26, 2023, 04:28 PM | |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | May 02, 2023 | Sale | $8.90 | 1,336 | 11,897 | 16,126 | May 03, 2023, 06:26 PM | |
| EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | Chief Financial Officer | May 23, 2022 | Option Exercise | $0.71 | 9,000 | 6,390 | 12,000 | May 25, 2022, 06:11 PM | |
| NVLS | Nivalis Therapeutics, Inc. | Carruthers R Michael | Exec Vice President / CFO | Dec 02, 2016 | Buy | $2.09 | 24,000 | 50,256 | 24,000 | Dec 05, 2016, 04:26 PM |
Menu